Solving unmet needs with a
proven track record.
We’re a dynamic company led by experienced leaders in the industry who are strategically building a portfolio with powerful opportunities in two emerging and growing categories: non-opioid pain relief and immunology.
Meet our industry-leading team, with a record of transformational drug development.
Immunology — harnessing
the body’s defenses
Explore our flexible partner path
Join our prestigious partners, such as Lilly, Boehringer Ingelheim, and NIH, in focusing on high-value markets with significant unmet need. We are poised to make meaningful headway, as governmental and private support for non-opioid pain drug development grows and we expand our commitment to the unlimited potential of new, broadband immunology medicines.